Search research articles
Contact Us
Filters
Showing results (101-110 of 299) with videos related to
Page
of 30
Sort By:
Annals of Surgery
|
October 1, 1985
Carcinoma of the pancreas. Therapeutic efficacy as defined by a serodiagnostic test utilizing a monoclonal antibody
D M Mahvi, W C Meyers, R C Bast, et al.
Cancer
|
September 25, 1991
Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclophosphamide, monoclonal antibodies, and magnetic microspheres
K C O'Briant, E J Shpall, L L Houston, et al.
International Journal of Cancer
|
November 15, 1987
Immunochemical characterization and radioimmunometric detection of molecules shed by human ovarian cancer
F Leoni, R C Bast, S Canevari, et al.
Cancer Research
|
November 1, 1977
Interindividual and intraindividual variations in aryl hydrocarbon hydroxylase in monocytes from monozygotic and dizygotic twins
T Okuda, E S Vesell, E Plotkin, et al.
American Journal of Obstetrics and Gynecology
|
January 1, 1994
The p53 tumor suppressor gene frequently is altered in gynecologic cancers
A Berchuck, M F Kohler, J R Marks, et al.
The American Journal of Pathology
|
May 1, 1996
Expression of alpha 6 and beta 4 integrins in serous ovarian carcinoma correlates with expression of the basement membrane protein laminin
A P Skubitz, R C Bast, E A Wayner, et al.
Seminars in Oncology
|
June 1, 1991
Summary of symposium: Biology and therapy of ovarian cancer
R F Ozols, T C Hamilton, W J Hoskins, et al.
American Journal of Clinical Pathology
|
January 1, 1983
Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types
S E Kabawat, R C Bast, W R Welch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 1999
The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expression
F Xu, Y Yu, X F Le, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 1999
Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV)
G S Hagopian, G B Mills, A R Khokhar, et al.
Page
of 30
Search research articles
Search
Showing results (101-110 of 299) with videos related to
Sort By:
Page
of 30
Annals of Surgery
|
October 1, 1985
Carcinoma of the pancreas. Therapeutic efficacy as defined by a serodiagnostic test utilizing a monoclonal antibody
D M Mahvi, W C Meyers, R C Bast, et al.
Cancer
|
September 25, 1991
Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclophosphamide, monoclonal antibodies, and magnetic microspheres
K C O'Briant, E J Shpall, L L Houston, et al.
International Journal of Cancer
|
November 15, 1987
Immunochemical characterization and radioimmunometric detection of molecules shed by human ovarian cancer
F Leoni, R C Bast, S Canevari, et al.
Cancer Research
|
November 1, 1977
Interindividual and intraindividual variations in aryl hydrocarbon hydroxylase in monocytes from monozygotic and dizygotic twins
T Okuda, E S Vesell, E Plotkin, et al.
American Journal of Obstetrics and Gynecology
|
January 1, 1994
The p53 tumor suppressor gene frequently is altered in gynecologic cancers
A Berchuck, M F Kohler, J R Marks, et al.
The American Journal of Pathology
|
May 1, 1996
Expression of alpha 6 and beta 4 integrins in serous ovarian carcinoma correlates with expression of the basement membrane protein laminin
A P Skubitz, R C Bast, E A Wayner, et al.
Seminars in Oncology
|
June 1, 1991
Summary of symposium: Biology and therapy of ovarian cancer
R F Ozols, T C Hamilton, W J Hoskins, et al.
American Journal of Clinical Pathology
|
January 1, 1983
Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types
S E Kabawat, R C Bast, W R Welch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 1999
The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expression
F Xu, Y Yu, X F Le, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 1999
Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV)
G S Hagopian, G B Mills, A R Khokhar, et al.
Page
of 30